Literature DB >> 3552726

Computer-aided design and physiological testing of a luteinising hormone-releasing hormone analogue for 'adjuvant-free' immunocastration.

C A Morrison, R V Fishleigh, D J Ward, B Robson.   

Abstract

An analogue of LHRH containing an extension of Gly-Cys at the carboxyl-terminus has been designed to permit reproducible coupling to a suitably modified carrier via a thioether bond. Potential energy calculations indicated that this analogue adopted a conformation in solution virtually identical to the type II' turn around Gly-6-Leu-7 predicted for native LHRH. Intradermal administration of a conjugate of this analogue with purified protein derivative of tuberculin to male rats previously primed with BCG vaccine rapidly led to complete testicular regression. This adjuvant-free immunisation protocol may represent an alternative to castration for the veterinary control of reproductive function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552726     DOI: 10.1016/0014-5793(87)80014-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue.

Authors:  R C Coope; P J Browne; C Yiangou; G S Bansal; J Walters; N Groome; S Shousha; C L Johnston; R C Coombes; J J Gomm
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  Down-regulation of a novel form of fibroblast growth factor receptor 1 in human breast cancer.

Authors:  C Yiangou; H Cox; G S Bansal; R Coope; J J Gomm; R Barnard; J Walters; N Groome; S Shousha; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Presence of exon 5-deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance.

Authors:  A J Desai; Y A Luqmani; J E Walters; R C Coope; B Dagg; J J Gomm; P E Pace; C N Rees; V Thirunavukkarasu; S Shousha; N P Groome; R Coombes; S Ali
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.